Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
A 48-year-old, otherwise healthy woman, with a new onset recurring chest pain over a period of 1 week was admitted for coronary angiography. Surprisingly, a tubular-shaped high-grade stenosis in the middle segment of the LAD (Fig. 1a and Video 1) was revealed, simultaneous with a clear dissection seen as a radiolucent lumen resembling a Type 1 spontaneous artery dissection (SCAD), extending from the middle part of the RCA to its distal segment (Fig. 2a). Filling of the distal part of the RCA through contralateral LAD collaterals as well as TIMI II flow at LAD, led to primary imaging-guided PCI of the LAD. Optical coherence tomography imaging (OCT) showed a dissection flap and concomitant intramural hematoma (Fig. 1b) attributing to Type 3 SCAD, which was treated by primary drug-eluting-stent implantation (Fig. 1c). During a follow-up appointment after 6 weeks, the patient still reported about recurring chest pain since the first intervention. Thus, staged PCI of the RCA was performed: the proximal dissected segment was crossed into the side branch using microcatheter support, followed by exchange to a double-lumen microcatheter, allowing the safe crossing to the distal RCA lumen by a Gaia-1 wire (after failed crossing using a floppy and then a Fielder XT-A wires) (Fig. 2b and Video 2). Long-segment drug-eluting-stent PCI was performed covering the dissected part completely (Fig. 2c).
×
×
SCAD is now known to be an important cause of myocardial infarction in young patients [1]. Although SCAD still considered as uncommon, awareness of both the disease as well as the definition of its pathophysiologic mechanisms were approved by intracoronary high-resolution OCT imaging recently (1, 2). Here, we present a rare case, in which simultaneously two different forms—representing both rare subtypes of SCAD—could be detected and successfully treated in two different vessels in the same patient.
Anzeige
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.
Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.
Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.
Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.
Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.
Update Kardiologie
Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.